- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/00 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patent holdings for IPC class C07D 513/00
Total number of patents in this class: 117
10-year publication summary
|
3
|
3
|
2
|
1
|
3
|
1
|
4
|
2
|
3
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3715 |
6 |
| Bristol-myers Squibb Company | 4812 |
4 |
| Boehringer Ingelheim International GmbH | 4529 |
3 |
| SpecGx LLC | 186 |
3 |
| Glaxo Group Limited | 4356 |
2 |
| Merck Sharp & Dohme Corp. | 2184 |
2 |
| Janssen Pharmaceutica N.V. | 3233 |
2 |
| Wyeth LLC | 614 |
2 |
| Bayer Animal Health GmbH | 202 |
2 |
| Amgen Inc. | 4348 |
2 |
| Merck Sharp & Dohme B.V. | 890 |
2 |
| Abbvie Inc. | 1843 |
2 |
| Progenics Pharmaceuticals, Inc. | 131 |
2 |
| Novartis AG | 10346 |
1 |
| F. Hoffmann-La Roche AG | 7835 |
1 |
| Samsung Display Co., Ltd. | 37860 |
1 |
| The Regents of the University of California | 20534 |
1 |
| Genentech, Inc. | 4065 |
1 |
| Pfizer Inc. | 3366 |
1 |
| Merck Patent GmbH | 5668 |
1 |
| Other owners | 76 |